Neuberger Berman Group LLC Grows Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Neuberger Berman Group LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 13.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 301,101 shares of the pharmaceutical company’s stock after acquiring an additional 35,292 shares during the […]

Related Keywords

Sanfordc Bernstein ,Stuarta Arbuckle ,Charlesf Wagner Jr , ,Blackrock Inc ,Vertex Pharmaceuticals Incorporated ,Barclays ,News Ratings For Vertex Pharmaceuticals Daily ,Securities Exchange Commission ,Vertex Pharmaceuticals ,Insider Transactions At Vertex Pharmaceuticals ,Vertex Pharmaceuticals Stock ,Quarter For Vertex Pharmaceuticals ,Vanguard Group Inc ,Neuberger Berman Group ,Geode Capital Management ,Vertex Pharmaceuticals Inc ,Vertex Pharmaceuticals Company Profile ,Pricet Rowe Associates Inc ,Get Rating ,Berman Group ,Street Corp ,Capital Management ,Pricet Rowe Associates ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,